Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with ...

A former executive at French drugmaker Ipsen was sentenced on Thursday to two months in a U.S. prison for illegally trading ...

A former Ipsen executive, Dishant Gupta, was sentenced to two months in prison for insider trading. He illegally profited ...

In a report released today, Lucy Codrington from Jefferies maintained a Hold rating on Ipsen (0MH6 – Research Report), with a price target of ...

BOSTON (Reuters) -A former executive at French drugmaker Ipsen was sentenced on Thursday to two months in a U.S. prison for illegally trading on inside information he learned about his company's plans ...

Genfit (GNFT) announced the final terms of the 2025 Oceanes repurchase proposal and the consent fee that would be paid to the holders of 2025 ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...

France's Ipsen has expanded its oncology pipeline by licensing a T-cell engager (TCE) therapy from Paris-based start-up Biomunex Pharmaceuticals. The deal – valued at up to $610 million ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

A former executive of a global pharmaceutical company in Boston was sentenced Thursday for earning more than $250,000 through ...